What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review
DOI:
https://doi.org/10.33448/rsd-v10i13.21074Keywords:
Osteonecrosis; Antiresorptive drugs; Bisphosphonates; Dental implant; Success rate.Abstract
Objective: To review the current literature and provide the latest information on anti-resorptive agent-induced osteonecrosis of the jaw (ARONJ), including our basic and clinical research findings, as well as discuss the risks of developing osteonecrosis in patients undergoing dental implant surgery in use of anti-resorptive drugs (ARDs). Methods: A literature review was performed using articles published in indexed journals based on Pubmed, Web of Science, Embase and Scopus databases. Results: Our results show that the placement of dental implants in patients treated with ARDs should be carefully evaluated, these patients are not free from complications and, therefore, the risk assessment should be done individually, as one of the most serious complications, although rare, is the ARONJ. Conclusion: Thus, all patients treated with this type of drug should be informed about the risk of implant loss or the possibility of osteonecrosis, being necessary to inform about the increased risk also patients who already have osteointegrated implants and will start therapy with bisphosphonates (BPT). And, in addition, establishing a relationship and collaboration between doctor, dentist and patient is essential for the good prognosis of these cases.
References
Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons (2007). American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 65(3), 369–376. https://doi.org/10.1016/j.joms.2006.11.003
American Dental Association Council on Scientific Affairs (2006). Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. Journal of the American Dental Association (1939), 137(8), 1144–1150. https://doi.org/10.14219/jada.archive.2006.0355
Ata-Ali, J., Ata-Ali, F., Peñarrocha-Oltra, D., & Galindo-Moreno, P. (2016). What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clinical oral implants research, 27(2), e38–e46. https://doi.org/10.1111/clr.12526
Baron, R., Ferrari, S., & Russell, R. G. (2011). Denosumab and bisphosphonates: different mechanisms of action and effects. Bone, 48(4), 677–692. https://doi.org/10.1016/j.bone.2010.11.020
Escobedo, M. F., Cobo, J. L., Junquera, S., Milla, J., Olay, S., & Junquera, L. M. (2020). Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. Journal of stomatology, oral and maxillofacial surgery, 121(1), 40–48. https://doi.org/10.1016/j.jormas.2019.04.012
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa (3ª edição). Editora Artes Médicas.
Ferreira, G. Z., Bachesk, A. B., Bachesk, A. B., Farah, G. J., Filho, L. I., Dos Santos Silva, R., Poluha, R. L., Danieletto-Zanna, C. F., & Gonçales, E. S. (2020). Oral Rehabilitation With Dental Implants and the Importance of a Preventive Evaluation for Osteonecrosis of the Jaws Associated With Medications. The Journal of oral implantology, 46(4), 431–437. https://doi.org/10.1563/aaid-joi-D-19-00275
Fugazzotto, P. A., Lightfoot, W. S., Jaffin, R., & Kumar, A. (2007). Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. Journal of periodontology, 78(9), 1664–1669. https://doi.org/10.1902/jop.2007.060514
Gelazius, R., Poskevicius, L., Sakavicius, D., Grimuta, V., & Juodzbalys, G. (2018). Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review. Journal of oral & maxillofacial research, 9(3), e2. https://doi.org/10.5037/jomr.2018.9302
Ghidini, G., Manfredi, M., Giovannacci, I., Mergoni, G., Sarraj, A., Mureddu, M., Giunta, G., Bonanini, M., Meleti, M., & Vescovi, P. (2017). Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Minerva stomatologica, 66(4), 135–140. https://doi.org/10.23736/S0026-4970.17.04056-0
Giovannacci, I., Meleti, M., Manfredi, M., Mortellaro, C., Greco Lucchina, A., Bonanini, M., & Vescovi, P. (2016). Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?. The Journal of craniofacial surgery, 27(3), 697–701. https://doi.org/10.1097/SCS.0000000000002564
Goss, A., Bartold, M., Sambrook, P., & Hawker, P. (2010). The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 68(2), 337–343. https://doi.org/10.1016/j.joms.2009.09.037
Granate-Marques, A., Polis-Yanes, C., Seminario-Amez, M., Jané-Salas, E., & López-López, J. (2019). Medication-related osteonecrosis of the jaw associated with implant and regenerative treatments: Systematic review. Medicina oral, patologia oral y cirugia bucal, 24(2), e195–e203. https://doi.org/10.4317/medoral.22691
Grant, B. T., Amenedo, C., Freeman, K., & Kraut, R. A. (2008). Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 66(2), 223–230. https://doi.org/10.1016/j.joms.2007.09.019
Guazzo, R., Sbricoli, L., Ricci, S., Bressan, E., Piattelli, A., & Iaculli, F. (2017). Medication-Related Osteonecrosis of the Jaw and Dental Implants Failures: A Systematic Review. The Journal of oral implantology, 43(1), 51–57. https://doi.org/10.1563/aaid-joi-16-00057
Ikebe, T. (2013). Pathophysiology of BRONJ: Drug-related osteoclastic disease of the jaw. Oral Science International,10:1-8.
Jacobsen, C., Metzler, P., Rössle, M., Obwegeser, J., Zemann, W., & Grätz, K. W. (2013). Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clinical oral investigations, 17(1), 167–175. https://doi.org/10.1007/s00784-012-0708-2
Jeffcoat M. K. (2006). Safety of oral bisphosphonates: controlled studies on alveolar bone. The International journal of oral & maxillofacial implants, 21(3), 349–353.
Kasai, T., Pogrel, M. A., & Hossaini, M. (2009). The prognosis for dental implants placed in patients taking oral bisphosphonates. Journal of the California Dental Association, 37(1), 39–42.
Kunchur, R., Need, A., Hughes, T., & Goss, A. (2009). Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 67(6), 1167–1173. https://doi.org/10.1016/j.joms.2009.02.004
López-Cedrún, J. L., Sanromán, J. F., García, A., Peñarrocha, M., Feijoo, J. F., Limeres, J., & Diz, P. (2013). Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. The British journal of oral & maxillofacial surgery, 51(8), 874–879. https://doi.org/10.1016/j.bjoms.2013.06.011
Marx R. E. (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 61(9), 1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1
Mücke, T., Krestan, C. R., Mitchell, D. A., Kirschke, J. S., & Wutzl, A. (2016). Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review. Seminars in musculoskeletal radiology, 20(3), 305–314. https://doi.org/10.1055/s-0036-1592367
Nisi, M., Izzetti, R., Gennai, S., Bellini, P., Graziani, F., & Gabriele, M. (2020). Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants. The Journal of craniofacial surgery, 31(4), 1037–1041. https://doi.org/10.1097/SCS.0000000000006283
Pichardo, S., van der Hee, J. G., Fiocco, M., Appelman-Dijkstra, N. M., & van Merkesteyn, J. (2020). Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). The British journal of oral & maxillofacial surgery, 58(7), 771–776. https://doi.org/10.1016/j.bjoms.2020.03.022
Rawal, S.Y., Hilal, G. (2020). Osteonecrosis and spontaneous exfoliation of dental implants associated with oral bisphosphonate therapy: a case report. Aust Dent J, 65(1):100-103. doi:10.1111/adj.12738
Rodan, G.A., Reszka, A.A. (2002). Bisphosphonate mechanism of action. Curr Mol Med, 2(6):571-577. doi:10.2174/1566524023362104
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., O'Ryan, F., & American Association of Oral and Maxillofacial Surgeons. (2014). American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 72(10), 1938–1956. https://doi.org/10.1016/j.joms.2014.04.031
Ruggiero, S.L., Dodson, T.B., Assael, L.A., Landesberg, R., Marx, R.É., Mehrotra, B. (2009). American Association of Oral and Maxillofacial Surgeons. Artigo de posição da Associação Americana de Cirurgiões Bucais e Maxilofaciais sobre osteonecrose da mandíbula relacionada a bifosfonatos - atualização de 2009. J Oral Maxillofac Surg, 67: 2–12.
Shibahara T. (2019). Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone. The Tohoku journal of experimental medicine, 247(2), 75–86. https://doi.org/10.1620/tjem.247.75
Stavropoulos, A., Bertl, K., Pietschmann, P., Pandis, N., Schiødt, M., & Klinge, B. (2018). The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis. Clinical oral implants research, 29 Suppl 18, 54–92. https://doi.org/10.1111/clr.13282
Stockmann, P., Nkenke, E., Englbrecht, M., Schlittenbauer, T., Wehrhan, F., Rauh, C., Beckmann, M. W., Fasching, P. A., Kreusch, T., Mackensen, A., Wullich, B., Schett, G., & Spriewald, B. M. (2013). Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 41(1), 71–75. https://doi.org/10.1016/j.jcms.2012.10.018
Tam, Y., Kar, K., Nowzari, H., Cha, H. S., & Ahn, K. M. (2014). Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates--a presentation of six consecutive cases. Clinical implant dentistry and related research, 16(5), 751–761. https://doi.org/10.1111/cid.12048
Vescovi P. (2012). Bisphosphonates and osteonecrosis: an open matter. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 9(3), 142–144.
Vescovi, P., Merigo, E., Meleti, M., Manfredi, M., Guidotti, R., & Nammour, S. (2012). Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 41(3), 214–221. https://doi.org/10.1111/j.1600-0714.2011.01091.x
Yip, J. K., Borrell, L. N., Cho, S. C., Francisco, H., & Tarnow, D. P. (2012). Association between oral bisphosphonate use and dental implant failure among middle-aged women. Journal of clinical periodontology, 39(4), 408–414. https://doi.org/10.1111/j.1600-051X.2012.01854.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Gabriela Sumie Yaguinuma Gonçalves; Leandro Marcel Soares Alves; Milena Steluti Marques
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
